MML Investors Services
CADL icon

MML Investors Services’s Candel Therapeutics CADL Stock Holding History

MML Investors Services’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.6K Buy
+10,325
New +$56.2K ﹤0.01% 2936
2025
Q2 		– Sell
-48,419
Closed -$274K – 2812
2025
Q1 		$274K Sell
48,419
-816
-2% -$6.67K ﹤0.01% 2357
2024
Q4 		$427K Buy
49,235
+26,922
+121% +$159K ﹤0.01% 2017
2024
Q3 		$155K Sell
22,313
-51,063
-70% -$317K ﹤0.01% 2480
2024
Q2 		$455K Buy
+73,376
New +$551K ﹤0.01% 1846

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MML Investors Services's CADL Position: Q1 2026 in Review

MML Investors Services opened a new position in Candel Therapeutics (CADL) in Q1 2026: 10,325 shares worth $50.6K. The stake represents ﹤0.01% of the portfolio and ranks #2936 among its holdings. This is a return to the name: MML Investors Services previously reported a position in CADL as recently as Q1 2025.

MML Investors Services first reported a position in CADL in Q2 2024 and has held it in 5 quarters since. The position peaked at $455K in Q2 2024. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • MML Investors Services held 10,325 shares of Candel Therapeutics worth $50.6K as of Q1 2026.
  • Candel Therapeutics was a new MML Investors Services position in Q1 2026.
  • Candel Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q1 2026, its #2936 holding.
  • MML Investors Services first reported a position in Candel Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • MML Investors Services's Candel Therapeutics position peaked at $455K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.